Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00482586 · ClinicalTrials.gov registry record
Quality of Life in Patients With Liver Cancer Treated With Image-Guided Therapy
A clinical trial of Metastatic Cancer and Liver Cancer, sponsored by Vanderbilt University.
- Completed
- Registry status
- 137
- Enrollment target
- 3
- Study locations
NCT00482586 is a study of Metastatic Cancer and Liver Cancer that has completed, run by Vanderbilt University. The registered enrollment target is 137 participants, below the 443-participant average among 109 other Metastatic Cancer trials with a reported enrollment target (69% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT00482586, a study of Metastatic Cancer and Liver Cancer, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 137 participants
- Enrollment target
- 3
- Study locations
Study Summary
RATIONALE: Gathering information about quality of life over time from patients with liver cancer treated with image-guided therapy may help the study of cancer in the future. PURPOSE: This clinical trial is gathering information about quality of life over time from patients with liver cancer treated with image-guided therapy.
Conditions Studied
Interventions
- OTHER medical chart review
- OTHER questionnaire administration
- PROCEDURE quality-of-life assessment
Study Locations (3)
Tennessee
- Vanderbilt-Ingram Cancer Center - Cool Springs - Nashville
- Vanderbilt-Ingram Cancer Center at Franklin - Nashville
- Vanderbilt-Ingram Cancer Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2003-10 |
| Est. Completion | 2015-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00482586
The ClinicalTrials.gov registry entry for NCT00482586 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 443-participant average among 109 other Metastatic Cancer trials with a reported enrollment target (69% lower). The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Metastatic Cancer appearing as the primary indexed condition, and to 3 interventions - of which medical chart review is the first listed.
NCT00482586 reports 3 study locations spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT00482586 about?
NCT00482586 is a clinical study titled "Quality of Life in Patients With Liver Cancer Treated With Image-Guided Therapy". RATIONALE: Gathering information about quality of life over time from patients with liver cancer treated with image-guided therapy may help the study of cancer in the future. PURPOSE: This clinical trial is gathering information about quality of life over time from patients with liver cancer treate...
What is the current status of trial NCT00482586?
This trial is currently completed. The enrollment target is 137 participants. The study started on 2003-10. Estimated completion is 2015-04.
What conditions does trial NCT00482586 study?
This clinical trial studies the following conditions: Metastatic Cancer, Liver Cancer.
What interventions are being tested in trial NCT00482586?
The interventions under investigation include: medical chart review (OTHER), questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE).
Who is sponsoring clinical trial NCT00482586?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00482586 being conducted?
This trial has 3 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metastatic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating Disparities in Precision Oncology
RECRUITING
-
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
RECRUITING · Phase 1
-
A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change
RECRUITING · Phase 2
-
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
RECRUITING · Phase 1
-
Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
RECRUITING · Phase 2
-
Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.